Advertisement

CQ28. Do Total Thyroidectomy and Lymph Node Dissection for Sporadic and Hereditary Medullary Carcinoma Improve the Prognosis?

  • Shinya Uchino
  • Daishu Miura
  • Takahiro Okamoto
Chapter

Abstract

Whether the extent of thyroidectomy or the execution and the extent of lymph node dissection affect the prognosis of patients with medullary carcinoma was investigated. Hereditary and sporadic medullary carcinomas were separately investigated.

Keywords

Total Thyroidectomy Medullary Carcinoma Calcitonin Level Lateral Node Metastasis Central Node Metastasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Miyazawa Y, Sakata H, Kawashima T et al (2004) (Text in Japanese) Rinsho Geka 59:413–417 [Case Series (CS)]Google Scholar
  2. 2.
    Iihara M, Yamashita T, Okamoto T et al (1997) A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan. Jpn J Clin Oncol 27:128–134 (CS)PubMedCrossRefGoogle Scholar
  3. 3.
    Kebebew E, Ituarte PH, Siperstein AE et al (2000) Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 88:1139–1148 (RS)PubMedCrossRefGoogle Scholar
  4. 4.
    Miyauchi A, Matsuzuka F, Hirai K et al (2002) Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations. World J Surg 26:1023–1028 (RS)PubMedCrossRefGoogle Scholar
  5. 5.
    Miyauchi A, Matsuzuka F, Hirai K et al (2000) Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma. World J Surg 24:1367–1372 (RS)PubMedCrossRefGoogle Scholar
  6. 6.
    Ito Y, Miyauchi A, Yabuta T et al (2009) Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: experience of a single institution. World J Surg 33:58–66 (RS)PubMedCrossRefGoogle Scholar
  7. 7.
    Grozinsky-Glasberg S, Benbassat CA, Tsvetov G et al (2007) Medullary thyroid cancer: a retrospective analysis of a cohort treated at a single tertiary care center between 1970 and 2005. Thyroid 17:549–556 (CS)PubMedCrossRefGoogle Scholar
  8. 8.
    Greenblatt DY, Elson D, Mack E et al (2007) Initial lymph node dissection increases cure rates in patients with medullary thyroid cancer. Asian J Surg 30:108–112 (RS)PubMedCrossRefGoogle Scholar
  9. 9.
    Dralle H, Scheumann GF, Proye C et al (1995) The value of lymph node dissection in hereditary medullary thyroid carcinoma: a retrospective, European, multicentre study. J Intern Med 238:357–361 (CS)PubMedCrossRefGoogle Scholar
  10. 10.
    Scollo C, Baudin E, Travagli JP et al (2003) Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 88:2070–2075 (RS)PubMedCrossRefGoogle Scholar
  11. 11.
    Machens A, Hauptmann S, Dralle H (2008) Prediction of lateral lymph node metastases in medullary thyroid cancer. Br J Cancer 95:586–591 (RS)Google Scholar
  12. 12.
    Machens A, Dralle H (2010) Biomarker-based risk stratification for previously untreated medullary thyroid carcinoma. J Clin Endocrinol Metab 95:2655–2663 (RS)PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2013

Authors and Affiliations

  1. 1.Department of SurgeryNoguchi Thyroid Clinic and Hospital FoundationBeppuJapan
  2. 2.Department of Breast and Endocrine SurgeryToranomon HospitalTokyoJapan
  3. 3.Department of Endocrine Surgery and Hygiene & Public Health IITokyo Women’s Medical UniversityTokyoJapan

Personalised recommendations